From March lows, the stock price of Thyrocare Technologies
has more-than-tripled from Rs 410 and of Dr Lal PathLabs
more-than-doubled from Rs 1,182 on the BSE. Analysts attribute the sharp rally in these stocks to healthy operational income due to higher revenue from Covid-19 tests.
According to Reuters report, Pfizer Inc's experimental Covid-19 vaccine was more than 90 per cent effective based on initial trial results, the company said on Monday, a major victory in the fight against a pandemic that has killed over a million people and battered the world's economy.
Pfizer and its German partner BioNTech SE said they had so far found no serious safety concerns and expected to seek U.S. authorization this month for emergency use of the vaccine, raising the possibility of a regulatory decision as soon as December. CLICK HERE TO READ FULL REPORT